510(k) K024062
K024062 is an FDA 510(k) premarket notification submitted by Bayer Corp. for the device "ASCENSIA BREEZE BLOOD GLUCOSE METER". The FDA issued a decision of Substantially Equivalent on March 3, 2003. The device falls under product code CGA (Glucose Oxidase, Glucose), a Class II device regulated under 21 CFR 862.1345. Bayer Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 3, 2003
- Date Received
- December 9, 2002
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Glucose Oxidase, Glucose
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type